학술논문
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
Document Type
Article
Author
Source
In: The Lancet Oncology . (The Lancet Oncology, March 2024, 25(3):388-399)
Subject
Language
English
ISSN
14745488
14702045
14702045